PT1291429E - Variante de splicing da glutamina-frutose-6-fosfatoamidotransferase e seu produto de expressão - Google Patents

Variante de splicing da glutamina-frutose-6-fosfatoamidotransferase e seu produto de expressão Download PDF

Info

Publication number
PT1291429E
PT1291429E PT01938602T PT01938602T PT1291429E PT 1291429 E PT1291429 E PT 1291429E PT 01938602 T PT01938602 T PT 01938602T PT 01938602 T PT01938602 T PT 01938602T PT 1291429 E PT1291429 E PT 1291429E
Authority
PT
Portugal
Prior art keywords
gene
expression product
amino acid
protein
splice variant
Prior art date
Application number
PT01938602T
Other languages
English (en)
Inventor
Tsutomu Fujiwara
Takashi Okamoto
Masashi Niimi
Hiroyuki Kyushiki
Yasuchika Yamamoto
Atsunori Ueyama
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of PT1291429E publication Critical patent/PT1291429E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1096—Transferases (2.) transferring nitrogenous groups (2.6)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
PT01938602T 2000-06-13 2001-06-12 Variante de splicing da glutamina-frutose-6-fosfatoamidotransferase e seu produto de expressão PT1291429E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000176631 2000-06-13
JP2000290679A JP4601143B2 (ja) 2000-06-13 2000-09-25 新規酵素遺伝子およびその発現産物

Publications (1)

Publication Number Publication Date
PT1291429E true PT1291429E (pt) 2008-12-15

Family

ID=26593812

Family Applications (1)

Application Number Title Priority Date Filing Date
PT01938602T PT1291429E (pt) 2000-06-13 2001-06-12 Variante de splicing da glutamina-frutose-6-fosfatoamidotransferase e seu produto de expressão

Country Status (15)

Country Link
US (1) US7091018B2 (pt)
EP (1) EP1291429B1 (pt)
JP (1) JP4601143B2 (pt)
KR (1) KR100882407B1 (pt)
CN (1) CN100390286C (pt)
AR (1) AR029130A1 (pt)
AT (1) ATE407212T1 (pt)
AU (2) AU2001264245B2 (pt)
CA (1) CA2412880C (pt)
DE (1) DE60135650D1 (pt)
DK (1) DK1291429T3 (pt)
ES (1) ES2312442T3 (pt)
PT (1) PT1291429E (pt)
TW (1) TWI232883B (pt)
WO (1) WO2001096574A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602006021421D1 (de) * 2005-06-20 2011-06-01 Exelixis Inc Ngsverfahren
US8106256B2 (en) * 2005-10-05 2012-01-31 Bayer Cropscience Ag Methods and means for producing hyaluronan
WO2008001505A1 (fr) * 2006-06-30 2008-01-03 Hokkaido System Science Co., Ltd. Composition pour la pénétration d'acides nucléiques
CN103301447B (zh) * 2013-06-25 2014-12-31 哈尔滨医科大学 DNA-PKcs在制备改变肿瘤细胞对MTX耐药性的药物中的应用
CN112980914A (zh) * 2019-12-12 2021-06-18 中国科学院大连化学物理研究所 Gfpt1基因作为靶点在筛选抗肿瘤药物中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993021330A1 (en) * 1992-04-22 1993-10-28 Zymogenetics, Inc. Human glutamine:fructose-6-phosphate amino-transferase
JPH1018683A (ja) * 1996-06-29 1998-01-20 Tesco Joho Center:Kk 吊下扉のレール装置
JP4175680B2 (ja) * 1996-08-13 2008-11-05 武田薬品工業株式会社 新規タンパク質およびそのｄｎａ
CA2212786A1 (en) * 1996-08-13 1998-02-13 Takeda Chemical Industries, Ltd. Novel glutamine:fructose-6-phosphate amidotransferase, its production and use
AU2216300A (en) * 1998-12-22 2000-07-12 G.D. Searle & Co. Glutamine: fructose-6-phosphate aminotransferase ii enzyme and their encoding nucleic acids

Also Published As

Publication number Publication date
TWI232883B (en) 2005-05-21
CA2412880A1 (en) 2002-12-13
DE60135650D1 (de) 2008-10-16
AU2001264245B2 (en) 2006-04-27
AU6424501A (en) 2001-12-24
ATE407212T1 (de) 2008-09-15
CA2412880C (en) 2010-05-04
AR029130A1 (es) 2003-06-04
EP1291429A1 (en) 2003-03-12
CN1436239A (zh) 2003-08-13
JP4601143B2 (ja) 2010-12-22
US7091018B2 (en) 2006-08-15
KR100882407B1 (ko) 2009-02-05
DK1291429T3 (da) 2009-01-19
ES2312442T3 (es) 2009-03-01
EP1291429B1 (en) 2008-09-03
WO2001096574A1 (fr) 2001-12-20
CN100390286C (zh) 2008-05-28
EP1291429A4 (en) 2004-05-26
KR20030011868A (ko) 2003-02-11
US20040132020A1 (en) 2004-07-08
JP2002065284A (ja) 2002-03-05

Similar Documents

Publication Publication Date Title
RU2353625C2 (ru) Миметики человеческого глюканоподобного пептида-1 и их применение в лечении диабета и родственных состояний
MD2311F2 (en) Obesity polypeptides, immunogenic fragment, analogue, human analogue and reduced human analogue, isolated molecule of nucleic acid, DNA molecule, detectable marked molecule of nucleic acid, vectors containing said DNA molecule, monoclonal antibody, polyclonal antibody and pharmaceutical composition for reduction of the animals body weight
KR20110061552A (ko) 할로겐 안정화된 인슐린
DE69027989D1 (de) Il-3 MIT ZUSÄTZLICHEN CYSTEINRESTEN UND CHEMISCHE MODIFIKATIONEN DAVON
DE69029406D1 (en) Polypeptid
WO2001092497A3 (en) Human pancreatic islet glucose-6-phosphatase
HK1089788A1 (en) A recombinant protein with cancer suppression action, its encoding gene and use
WO2015061351A1 (en) Chimeric fibroblast growth factor (fgf) 2/fgf1 peptides and methods of use
WO2002061076A1 (en) Adiponectin-associated protein
WO2003038112B1 (en) A composition and method to alter lean body mass and bone properties in a subject
KR980002066A (ko) 변이형 인간 성장호르몬 및 그의 용도
PT1291429E (pt) Variante de splicing da glutamina-frutose-6-fosfatoamidotransferase e seu produto de expressão
EP1279744A3 (en) Identification and use of molecules implicated in pain
AU8748198A (en) Carcinostatic agents
AU2001248822A1 (en) Gd3-mimetic peptides
WO2006063800A8 (en) Cloning of honey bee allergen
ATE490324T1 (de) Nukleinsäuren kodierend für polypeptide mit chips aktivität
ATE327321T1 (de) Zyklische depsipeptid-synthasen, deren gene und system zur massenproduktion von zyklischen depsipeptiden
DE69925116D1 (de) Neue, physiologisch aktive peptide und ihre verwendung.
RU97104072A (ru) Модуляторы веса тела, соответствующие нуклеиновые кислоты и протеины, а также их применение для диагностических и терапевтических целей
JP2003113111A5 (pt)
PT659883E (pt) Proteina p140 e adn que a codifica
Nestor et al. Surfactant‐modified parathyroid hormone fragments with high potency and prolonged action: Structure‐informed design using glycolipid surfactant conjugation
EP1568775A4 (en) CANCER ASSOCIATED GEN
NZ505350A (en) DNA encoding a tumour antigen peptide (43 kDa) for diagnosis or treatment of tumours